ReviewCJC open2025
A Primer on Large Language Models (LLMs) and ChatGPT for Cardiovascular Healthcare Professionals.
Review in CJC open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A large language model for complex cardiology care.Nature medicine · 2026Trial
- Reimagining cardiac care with AI, LLMs, blockchain, and metaverse.Global cardiology science & practice · 2026Review
- Cardiology-Chat: A Multi-LLMs Powered System for Cardiac Diagnostic Reasoning and Clinical Support.IEEE journal of translational engineering in health and medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Generative artificial intelligence (AI), particularly large language models (LLMs), such as ChatGPT, is transforming healthcare by offering novel ways to synthesize and communicate medical knowledge. This development is especially relevant in cardiology, as patient education, clinical decision-making, and administrative workflows play pivotal roles in this area. ChatGPT, originally built on GPT-3 and refined into GPT-4, can simplify complex cardiology literature, translate technical explanations into plain language, and address questions across different linguistic backgrounds. Studies show that although ChatGPT demonstrates considerable promise in performing text-based tasks-ranging from passing portions of the European Exam in Core Cardiology to creating patient-friendly educational materials-its inability to interpret images remains a major limitation. Meanwhile, concerns around false information, data bias, and ethical issues highlight the need for careful oversight. Future directions include integrating LLMs with computer-vision modules for image-based diagnostics and combining unstructured patient data to improve risk prediction and phenotyping. Social-media research suggests that chatbots sometimes provide more-empathetic responses than do physicians, underscoring both their potential advantages and complexities. LLM-based tools can also generate letters for insurance prior authorizations or appeals, helping reduce administrative burden. New multimodal approaches, such as ChatGPT Vision, have the potential to enable direct image processing, although clinical validation of this function is yet to be established. The judicious integration of ChatGPT and other LLMs into cardiology requires ongoing validation, robust regulatory frameworks, and strong ethical guidelines to ensure patient privacy, avoid misinformation, and promote equitable healthcare delivery. This review aims to provide a primer on LLMs for cardiovascular professionals, summarizing key applications, current limitations, and prospects in this rapidly evolving field of digital health.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.